Posts from October 2018.
The DEA’s recent decision to reschedule certain FDA-approved, cannabis-derived CBD drugs, which includes only the drug Epidiolex at current, has many under the false impression that CBD is now completely legal on the federal level. But this is not yet the case. And unfortunately, this false impression could lead to disastrous consequences for financial institutions’ banking businesses selling CBD products and failing to properly report those businesses and their transactions.
Welcome to the Cannabis Business Legal News blog where attorneys from Amundsen Davis blog about all things cannabis business and legal news related.
RSS Feed